![]() | Up a level |
Number of items: 1.
Girard, Nicolas, Bar, Jair, Garrido, Pilar, Garassino, Marina C, McDonald, Fiona, Mornex, Francoise, Filippi, Andrea R, Smit, Hans JM, Peters, Solange, Field, John K ORCID: 0000-0003-3951-6365 et al (show 13 more authors)
(2023)
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.
JOURNAL OF THORACIC ONCOLOGY, 18 (2).
pp. 181-193.